首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素钙干预肺源性心脏病合并冠心病后QT离散度及JT离散度的变化
引用本文:支梦和,刘进宝.低分子肝素钙干预肺源性心脏病合并冠心病后QT离散度及JT离散度的变化[J].临床医学,2009,29(12):5-6.
作者姓名:支梦和  刘进宝
作者单位:山西省大同市第七人民医院呼吸科,大同,037005
摘    要:目的观察应用低分子肝素钙干预肺源性心脏病合并冠心病患者后QT离散度(QTcd)、JT离散度(JTcd)的变化。方法将145例肺源性心脏病合并冠心病患者随机分成两组,其中干预组76例,给予低分子肝素钙干预,对照组69例,给予常规治疗。观察两丑治疗前后QTcd、JTcd的变化情况。结果干预组与对照组在治疗前QTcd、JTcd差异无壳计学意义(P〉0.05),治疗后干预组QTcd、JTcd较对照组明显改善(P〈0.01)。结记低分子肝素钙对肺源性心脏病合并冠心病患者的QTcd、JTcd有显著改善作用。

关 键 词:低分子肝素钙  肺源性心脏病  冠心病  QT离散度  JT离散度

Changing of QTcd and JTcd in pulmonary heart disease with coronary heart disease intervened by low molecular weight calcium heparin
ZHI Menghe,LIU Jinbao.Changing of QTcd and JTcd in pulmonary heart disease with coronary heart disease intervened by low molecular weight calcium heparin[J].Clinical Medicine,2009,29(12):5-6.
Authors:ZHI Menghe  LIU Jinbao
Institution:ZHI Menghe,LIU Jinbao.Department of Respiratory,the Seventh People's Hospital of Datong,Datong 037005,China
Abstract:Objective To observe the changing of QTcd and JTcd in pulmonary heart disease with coronary heart disease intervened by low molecular weight calcium heparin.Methods One hundred and forty-five patients(pulmonary heart disease with coronary heart disease)were divided into two group randomly.The intervened group(n=76)were intervened by low molecular weight calcium heparin.The comparison group(n=69)were given normal treatments.Their changing of QTcd and JTcd were observed and analysed.Results There was not sign...
Keywords:Low molecular weightcalcium heparin  Pulmonary heart disease  Coronary heart disease  QTcd  JTcd  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号